
    
      Prospective, randomized, open-label, blinded endpoint study. Patients presenting with
      symptoms of AIS who have evidence of a moderate-large infarct volume (Non-contrast CT Alberta
      Stroke Program Early CT score [NCCT ASPECTS] 2-5 in the anterior circulation will be assigned
      to either best medical management alone (including IV rtPA) or intra-arterial treatment (IAT)
      with mechanical thrombectomy added to best medical management. Each treated patient will be
      followed and assessed for 3 months after randomization.
    
  